Medical Xpress

FEBRUARY 21, 2025

Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain stimulation. The findings are published in the Journal of Neural Engineering. The findings are published in the Journal of Neural Engineering.

Engineer 106

Engineer Development Research 106

Medical Xpress

MARCH 1, 2025

Studies reveal that people with Down syndrome (DS) have over a 90% lifetime risk of developing dementia caused by Alzheimer's disease (AD) as they age.

Engineer 97

Engineer Development Research 97

Pharmaceutical Technology

FEBRUARY 13, 2023

While several therapeutics are available for treating symptoms associated with epilepsy, researchers and patients have strongly called out the need for more holistic treatments that would address the condition as a whole. Meanwhile, others are researching the link between gene variation and different responses to treatments.

Research 264

Research Gene Gene Therapy Genome 264

Scienmag

JULY 14, 2022

A civil engineering researcher at The University of Texas at Arlington will utilize a $122,000 grant to develop an automatic crack evaluation (ACE) system that could save time and money and prioritize maintenance for roads, bridges and runways.

Engineer 89

Engineer Development Research 89

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 19, 2024

Different types of brain cells could age at different speeds, and that may help explain the development of Alzheimer’s disease.

Engineer 246

Engineer Development Clinical Trials Clinical Trials 246

Pharmaceutical Technology

NOVEMBER 29, 2022

Researchers at City of Hope in the US have developed a new potential therapy to treat glioblastoma multiforme (GBM), a kind of brain cancer. These viruses are engineered genetically for killing cancer. The post City of Hope researchers develop new brain cancer therapy appeared first on Pharmaceutical Technology.

Development 130

Development Research Antibody Engineer 130

Scienmag

FEBRUARY 16, 2022

University of Houston researchers have received $4.4 Department of Energy’s Advanced Research Projects Agency-Energy (ARPA-E) for two projects developed in the Cullen College of Engineering and Texas Center for Superconductivity at the University of Houston (TcSUH). million from the U.S.

Development 94

Development Research Engineer 94

Pharma Times

JANUARY 7, 2022

The platform integrates primary human tissue samples into early target and drug discovery research.

Engineer 123

Engineer Medicine Development Drugs 123

STAT News

JULY 28, 2022

In biopharma research and development, laboratory data now exist in petabytes. Now common on biotech job boards are positions like cloud engineer, data scientist, automation engineer, software engineer, machine learning engineer, and computational biologist. Continue to STAT+ to read the full story…

Engineer 105

Engineer Scientist Vaccination Vaccine 105

Pharmaceutical Technology

DECEMBER 19, 2022

With the latest development, Sanofi will licence a NK cell engager programme that acts on B7H3 from the antibody-based NK cell engager therapeutics (ANKET) platform of Innate. On choosing the candidate, the company will oversee the complete development, production and marketing.

Development 264

Development Engineer Clinical Trials Clinical Trials 264

Pharmaceutical Technology

MAY 5, 2023

TFF Pharmaceuticals and the National Institute of Environmental Health Sciences (NIEHS) have signed an agreement for the development of dry powder formulations of high molecular weight hyaluronan (HMW-HA) for respiratory diseases.

Development 162

Development In-Vivo In-Vitro Engineer 162

Medical Xpress

JANUARY 2, 2023

Researchers at UCSF have developed a novel, potentially life-saving approach that may prevent antibodies from triggering immune rejection of engineered therapeutic and transplant cells.

Antibody 128

Antibody Research Engineer Development 128

Medical Xpress

NOVEMBER 23, 2022

A KAIST research team led by Ph.D. candidate Jae Hee Lee and Professor Keon Jae Lee from the Department of Materials Science and Engineering has developed a surface-lighting microLED patch for UV-induced melanogenesis inhibition. The team's research was published in Advanced Healthcare Materials.

Development 98

Development Research Engineer 98

Pharmaceutical Technology

APRIL 14, 2023

Ginkgo Bioworks (Ginkgo) and the Wisconsin Alumni Research Foundation (WARF) have collaborated to discover next-generation GD2 CAR T-cell therapies to treat solid tumours. Ginkgo will partner with researchers from Wisconsin-Madison to discover new and improved GD2 CAR designs with improved persistence, fitness and proliferation.

In-Vivo 264

In-Vivo Gene Therapy In-Vitro Engineer 264

pharmaphorum

SEPTEMBER 16, 2022

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. Verily’s Immune Profiler platform is “a discovery engine consisting of proprietary immune profiling lab workflow, growing multi-omic database, and advanced analytical tools”.

Development 135

Development Research Drugs Clinical Trials 135

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 27, 2022

The Indian Institute of Science (IISc) researchers from the Centre for Nano Science and Engineering (CeNSE) have developed fabricated pressure sensors that use paper as the medium which find applications in healthcare. This is because medical treatments depend considerably on accurate and precise measurement of pressure.

Development 100

Development Research Engineer Clinical Trials 100

Pharmaceutical Technology

AUGUST 11, 2022

GentiBio and Bristol Myers Squibb (BMS) have signed a multi-year partnership agreement for developing new engineered Treg therapies for inflammatory bowel disease (IBD) patients. These therapies will be developed for re-instating immune tolerance and repairing tissue in IBD.

Development 130

Development Engineer Gene Therapy Clinical Trials 130

Pharmaceutical Technology

SEPTEMBER 29, 2022

Scribe Therapeutics and Sanofi have signed a strategic partnership to expedite the development of breakthrough clustered regularly interspaced short palindromic repeats (CRISPR)-based cell therapies for cancer. Scribe is also entitled to receive potential payments worth over $1bn on meeting development and commercial milestones.

Development 130

Development In-Vivo Genome Genomics 130

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 22, 2022

The Indian Institute of Science (IISc), Centre for BioSystems Science and Engineering, has designed a new method to deliver a vaccine candidate for tuberculosis (TB). The research involves using spherical vesicles secreted by bacteria coated on gold nanoparticles which can then be delivered to the immune cells.

Vaccination 100

Vaccination Vaccine Research Bacteria 100

Pharmaceutical Technology

APRIL 28, 2023

Generate Biomedicines has signed a co-development and commercialisation agreement with the University of Texas MD Anderson Cancer Center to expedite the development of new protein therapeutics for oncology using generative AI. It enables innovative and collaborative research to rapidly bring new treatment options to patients.

Development 130

Development Clinical Trials Clinical Trials Protein 130

Pharmaceutical Technology

JULY 20, 2022

Avista Therapeutics, a University of Pittsburgh Medical Center (UPMC) spinout, has entered a collaboration with Roche for developing new AAV gene therapy vectors for eyes. Roche will also make further payments to Avista during the collaboration’s research phase and clinical, sales-based milestone and royalty payments for resulting products.

Gene Therapy 147

Gene Therapy Gene Development In-Vivo 147

Pharmaceutical Technology

OCTOBER 12, 2022

Nimbus Therapeutics and Eli Lilly and Company (Lilly) have signed a research partnership and licence agreement to develop and market new therapies that activate a specific AMPK isoform to treat metabolic diseases. The company will lead the research activities, while Lilly will undertake the global development and marketing activities.

Development 130

Development Protein Engineer Drugs 130

Pharmaceutical Technology

AUGUST 18, 2022

Atomwise and Sanofi have entered a strategic and exclusive research partnership to use the former’s artificial intelligence (AI)-driven AtomNet platform to discover and research up to five drug targets computationally. Furthermore, Sanofi will make tiered royalty payments on products that are developed under this partnership.

Drugs 246

Drugs Engineer Medicine Sales 246

Pharma Marketing Network

NOVEMBER 23, 2024

Just as a chef relies on quality ingredients for the perfect dish, marketers depend on cutting-edge research to craft campaigns that resonate with their audience. The Connection Between Pharma Research and Marketing Effective marketing starts with understanding your audience.

Marketing 52

Marketing Research Big Data Medicine 52

Pharma Times

APRIL 12, 2024

Both partners’ will leverage their nuclear research facilities and expertise to develop new health interventions

Medicine 141

Medicine Research Development Production 141

Scienmag

JULY 13, 2022

Researchers in the Oregon State University College of Engineering have harnessed the power of artificial intelligence to help protect bees from pesticides. Researchers in the Oregon State University College of Engineering have harnessed the power of artificial intelligence to help protect […]. CORVALLIS, Ore.

Research 86

Research Engineer Development 86

Pharmaceutical Technology

APRIL 3, 2023

Innate Pharma has signed an exclusive licence agreement with Takeda to enable research and development of antibody drug conjugates (ADCs) against an undisclosed target, primarily focusing on coeliac disease. In addition, Innate will receive royalties on possible net sales of any commercial product to be developed under the licence.

Development 130

Development Antibody Pharma Production Engineer 130

Pharmaceutical Technology

APRIL 20, 2023

The funds will support Maxion’s KnotBody platform to develop antibodies to treat autoimmune diseases. As per the company, this allows for a longer half-life in the body and gives the ability for further biomolecular engineering. As per Maxion, there are more than 80 types of autoimmune conditions.

Development 130

Development Antibody Engineer Clinical Trials 130

BioPharma Reporter

MAY 5, 2023

Mekonos, a biotech platform developing cell therapies, has announced a new research collaboration with bit.bio, a synthetic biology company providing human cells for research, drug discovery and cell therapy.

Engineer 75

Engineer Research Development Drugs 75

XTalks

JUNE 10, 2021

Researchers at Massachusetts Institute of Technology (MIT) have designed the world’s first digital fabric fiber that contains digital devices which can sense, analyze and store health data, and use it to infer a person’s activity and state of health. This would generate exciting new possibilities for digital health applications.

Research 111

Research Development Containment Engineer 111

Scienmag

MAY 2, 2022

A University of Minnesota Twin Cities research team has developed a new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by a smartphone. The innovation opens the door for faster and more affordable at-home medical testing.

Development 93

Development Research Engineer 93

Pharmaceutical Technology

DECEMBER 14, 2022

Merck and Synplogen have signed a non-binding Memorandum of Understanding (MoU) to expedite the development and manufacturing of viral vector-based gene therapy applications. The firms intend to merge their expertise to provide simplified viral vector gene therapy development, production and testing in Japan.

Gene Therapy 130

Gene Therapy Gene Development Manufacturing 130

Scienmag

MAY 19, 2022

The Air Force Research Laboratory’s Minority Leaders Research Collaborative Program (ML-RCP) has awarded a two-year, $150,000 award to Ethan Ahn, an assistant professor of the UTSA Electrical and Computer Engineering Department.

Research 91

Research Engineer Development 91

Scienmag

JULY 5, 2022

An international team of scientists featuring Florida State University researchers has developed a model that predicts the spread of vortices in so-called superfluids, work that provides new insight into the physics that govern turbulence in quantum fluid systems such as superfluid neutron stars.

Research 93

Research Engineer Scientist Development 93

Pharmaceutical Technology

MAY 25, 2023

ElevateBio has raised $401m in a Series D financing round for advancing its technology platforms to expedite the design, production and development of cell and gene therapies. The technology platforms include the Life Edit gene editing platform, an RNA, cell, protein, vector engineering and induced pluripotent stem cells (iPSCs) platform.

Gene Therapy 243

Gene Therapy Gene Gene Editing Development 243

Scienmag

MAY 23, 2022

The Icahn School of Medicine at Mount Sinai has launched a new research center devoted to understanding how epigenomics influences the nervous system under both healthy and disease conditions.

Research 86

Research Engineer Medicine Development 86

XTalks

JANUARY 16, 2025

These stem cells are engineered to develop into dopamine-producing neurons, which are progressively lost in Parkinsons disease. This year has started strong for Parkinsons disease research with progress in several clinical trials and medical devices. As of 2023, there were approximately 2.7

Trials 104

Trials Clinical Trials Clinical Trials Gene Therapy 104